Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,995 | -27,202 | -19,873 | -12,678 | -5,866 |
| Depreciation Amortization | 126 | 89 | 11 | 5 | 2 |
| Accounts payable and accrued liabilities | 660 | 2,189 | 1,975 | 1,143 | -62 |
| Other Working Capital | 569 | 3,800 | 4,201 | 2,273 | 1,260 |
| Other Operating Activity | 4 | -157 | -379 | -5 | 718 |
| Operating Cash Flow | $-6,636 | $-21,281 | $-14,065 | $-9,262 | $-3,948 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -105 | -99 | -22 | -11 |
| Investing Cash Flow | $-3 | $-105 | $-99 | $-22 | $-11 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,000 | N/A | N/A | N/A |
| Common Stock Issued | 15,041 | 33 | 15 | N/A | N/A |
| Other Financing Activity | 0 | -65 | 0 | 0 | 0 |
| Financing Cash Flow | $15,041 | $9,968 | $15 | $N/A | $N/A |
| Beginning Cash Position | 36,619 | 48,036 | 48,036 | 48,036 | 48,036 |
| End Cash Position | 45,020 | 36,619 | 33,888 | 38,752 | 44,078 |
| Net Cash Flow | $8,401 | $-11,418 | $-14,149 | $-9,285 | $-3,958 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,636 | -21,281 | -14,065 | -9,262 | -3,948 |
| Capital Expenditure | -3 | -105 | -99 | -22 | -11 |
| Free Cash Flow | -6,639 | -21,386 | -14,163 | -9,285 | -3,958 |